Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Taste receptor" is a generic term that refers to a large family of related but distinct proteins, not a single molecular entity. The term encompasses multiple specific receptors (e.g., TAS1R1, TAS2R38), each with unique properties and functions. For structured data or drug discovery purposes, the name should be specified further (e.g., "Bitter taste receptor TAS2R38" or "Sweet taste receptor TAS1R2/TAS1R3"). A **taste receptor**, also known as a gustatory or tastant receptor, is any member of two main families of G protein-coupled receptors responsible for detecting chemical stimuli that produce the sensation of taste. In vertebrates: - **Type I ("sweet/umami") receptors**, formed by heterodimers such as *TAS1R2/TAS1R3* and *TAS1R1/TAS1R3*, detect sweet and umami flavors. - **Type II ("bitter") receptors**, encoded by the *TAS2R* gene family (~25 members in humans), detect structurally diverse bitter compounds including many plant alkaloids and some pharmaceuticals.[6][7][9] Taste GPCRs reside on specialized epithelial cells within taste buds located mainly on the tongue but also throughout parts of the upper gastrointestinal tract. Upon ligand binding—such as sugars for sweet or alkaloids for bitter—the activated GPCR triggers intracellular signaling cascades resulting in neurotransmitter release onto afferent nerve fibers. Beyond their role in gustation, certain bitter-taste GPCRs (*e.g.*, TAS2Rs) have been found expressed outside oral tissues where they contribute to innate immune responses—for example by detecting bacterial metabolites on airway epithelia.[6] Genetic variation among individuals leads to significant diversity in sensitivity toward different tastants. Because “taste receptor” refers collectively to an entire superfamily rather than one molecule—and because each subtype has distinct ligands/functions—the term is too broad for precise scientific use without further specification.[6] Note: While not classically associated with major diseases like cancer or cardiovascular disease, certain polymorphisms in bitter receptors are linked to differences in dietary preference and may influence susceptibility to respiratory infections due to their role in airway immunity.
Drugs/compounds act primarily as: Agonists binding to the orthosteric site within the transmembrane domain of GPCRs, activating downstream signaling pathways leading to neurotransmitter release and sensory perception.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taste receptor.